Arch Neurol -- Table of Contents (Vol. 54 No. 4, April 1997)

You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Table of Contents

ARTICLES

Alzheimer disease and frontotemporal dementia
L. Rozzini; G. Lussignoli; A. Padovani; A. Bianchetti; M. Trabucchi
Arch Neurol. 1997;54:350.

Rodent models of stroke
S. R. Neff
Arch Neurol. 1997;54:350-351.

Traditional risk factors for stroke in the young
C. Marini; A. Carolei
Arch Neurol. 1997;54:351-352.

Multiple sclerosis screening examinations
W. W. Beatty
Arch Neurol. 1997;54:352.

Association between migraine and stroke in a large-scale epidemiological study of the United States
K. R. Merikangas; B. T. Fenton; S. H. Cheng; M. J. Stolar; N. Risch
Arch Neurol. 1997;54:362-368.
ABSTRACT

Neuropsychological characteristics of the syndrome of mesial temporal lobe epilepsy
B. P. Hermann; M. Seidenberg; J. Schoenfeld; K. Davies
Arch Neurol. 1997;54:369-376.
ABSTRACT

'Complicated' autosomal dominant familial spastic paraplegia is genetically distinct from 'pure' forms
H. Meierkord; P. Nurnberg; A. Mainz; K. Marczinek; M. Mrug; J. Hampe
Arch Neurol. 1997;54:379-384.
ABSTRACT

Startle responses in hereditary hyperekplexia
M. A. Tijssen; L. M. Voorkamp; G. W. Padberg; J. G. van Dijk
Arch Neurol. 1997;54:388-393.
ABSTRACT

Double-blind crossover study with physostigmine in patients with degenerative cerebellar diseases
K. Wessel; K. Langenberger; M. F. Nitschke; D. Kompf
Arch Neurol. 1997;54:397-400.
ABSTRACT

The localizing value of a quadrantanopia
D. M. Jacobson
Arch Neurol. 1997;54:401-404.
ABSTRACT

Hearing loss and antiretroviral therapy in patients infected with HIV-1
C. M. Marra; H. A. Wechkin; W. T. Longstreth Jr; T. S. Rees; C. L. Syapin; G. A. Gates
Arch Neurol. 1997;54:407-410.
ABSTRACT

Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group
R. J. Ellis; R. Deutsch; R. K. Heaton; T. D. Marcotte; J. A. McCutchan; J. A. Nelson; I. Abramson; L. J. Thal; J. H. Atkinson; M. R. Wallace; I. Grant
Arch Neurol. 1997;54:416-424.
ABSTRACT

Cerebellar atrophy decreases the threshold of carbamazepine toxicity in patients with chronic focal epilepsy
U. Specht; T. W. May; M. Rohde; V. Wagner; R. C. Schmidt; M. Schutz; P. Wolf
Arch Neurol. 1997;54:427-431.
ABSTRACT

Impaired upper limb coordination in alcoholic cerebellar degeneration
D. Johnson-Greene; K. M. Adams; S. Gilman; K. J. Kluin; L. Junck; S. Martorello; M. Heumann
Arch Neurol. 1997;54:436-439.
ABSTRACT

The effect of robot-assisted therapy and rehabilitative training on motor recovery following stroke
M. L. Aisen; H. I. Krebs; N. Hogan; F. McDowell; B. T. Volpe
Arch Neurol. 1997;54:443-446.
ABSTRACT

Sensory perception in Parkinson disease
E. E. Jobst; M. E. Melnick; N. N. Byl; G. A. Dowling; M. J. Aminoff
Arch Neurol. 1997;54:450-454.
ABSTRACT

T-cell interferon gamma binding in patients with dementia of the Alzheimer type
P. Bongioanni; B. Boccardi; M. Borgna; M. Castagna; C. Mondino
Arch Neurol. 1997;54:457-462.
ABSTRACT

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease
N. C. Bodick; W. W. Offen; A. I. Levey; N. R. Cutler; S. G. Gauthier; A. Satlin; H. E. Shannon; G. D. Tollefson; K. Rasmussen; F. P. Bymaster; D. J. Hurley; W. Z. Potter; S. M. Paul
Arch Neurol. 1997;54:465-473.
ABSTRACT

Hypothesis III. Tourette syndrome is only one of several causes of a developmental basal ganglia syndrome
D. Palumbo; A. Maughan; R. Kurlan
Arch Neurol. 1997;54:475-483.
ABSTRACT

Dementia improvement with cytotoxic chemotherapy. A case of Alzheimer disease and multiple myeloma
R. M. Keimowitz
Arch Neurol. 1997;54:485-488.
ABSTRACT